<i>ESR1</i> Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients

David Chu, Costanza Paoletti, Christina L. Gersch, +26

Clinical Cancer Research

Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms

Costanza Paoletti, Andi K. Cani, José M. Larios, +24

Cancer Research

Evidence for Association of SNPs in <i>ABCB1</i> and <i>CBR3</i> , but not <i>RAC2, NCF4, SLC28A3</i> or <i>TOP2B</i> , with Chronic Cardiotoxicity in a Cohort of Breast Cancer Patients Treated with Anthracyclines

Daniel L. Hertz, Megan E.V. Caram, Kelley M. Kidwell, +10

Pharmacogenomics

Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer

N. Lynn Henry, Todd C. Skaar, Jessica Dantzer, +13

Breast Cancer Research and Treatment

Genetic AssociationsBreast OncologyMedicinePharmacologyPathology +6

Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer

Thomas L. Gonzalez, Molly Hancock, Siqi Sun, +7

Breast Cancer Research and Treatment

Ligand-binding Domain MutationsBreast OncologyHormonal ReceptorEstrogen ReceptorMolecular Biology +10

Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor–Positive Breast Cancers

Andrea M. Pesch, Nicole Hirsh, Benjamin C. Chandler, +10

Clinical Cancer Research

PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer

Elizabeth P. Darga, Emily M. Dolce, Fang Fang, +13

PLoS ONE

Predictors of recovery of ovarian function during aromatase inhibitor therapy

N. Lynn Henry, Rong Xia, Mousumi Banerjee, +8

Annals of Oncology

Hormonal ContraceptiveFertilityMedicineGynecologyAromatase +8

Discovery of <b>ERD-3111</b> as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity

Zhixiang Chen, Biao Hu, Rohan Kalyan Rej, +17

Journal of Medicinal Chemistry

Concordance Between CYP2D6 Genotypes Obtained From Tumor-Derived and Germline DNA

James M. Rae, Meredith M. Regan, Jacklyn N. Thibert, +8

JNCI Journal of the National Cancer Institute

Breast OncologyCyp2d6 GenotypeGeneticsDna AnalysisPathology +18